According to immunohistochemistry, five clinico-pathologic breast cancer subtypes were identified: luminal A-like, luminal B-like HER2 negative, luminal B-like HER2 positive, HER2 positive, and triple-negative [4]. Here, ERBB2 is linked to breast carcinoma.